#CoronaVirus #COVID19 #biotechnology #CoronaOutbreak #CoronaPandemic #biospace #lifesciences #pharmaceuticals #Biopharma #biotech

Career And Jobs

On Apr 13, 2020

@IAmBiotech shared

#Biopharma Update on the Novel #Coronavirus #COVID19 https://t.co/pSgEym0n3y https://t.co/0FE4XDKH39

Open

Biopharma Update on the Novel Coronavirus: April 10

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.

On Apr 8, 2020

@biospace shared

Biopharma Update on the Novel Coronavirus: April 8 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/bnmP3Hi2J3

Open

Biopharma Update on the Novel Coronavirus: April 8

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.

On Apr 8, 2020

@broadinstitute shared

RT @DanaFarberNews: Congratulations to Dana-Farber’s Steven Corsello, MD (@corsellos), founder of the Drug Repurposing Hub at the @broadinstitute. Dr. Corsello has been recognized by @endpts as one of ‘The 20 under 40 in Biopharma:’ https://t.co/3lcQS0Kom1 #20under40 https://t.co/5Tf2Q0lsRs

Open

The 20 under 40: Inside the next generation of biopharma leaders

endpts.com

“Each generation needs a new music,” Francis Crick wrote in 1988, reflecting back on his landmark discovery. Crick was 35, then, in 1953, when he began working with a 23-year-old named ...

On Apr 9, 2020

@MassBio shared

Despite stock market volatility caused by #COVID19, the first quarter of 2020 was the single largest quarter ever for #Biopharma #VentureFunding in the US, topping in at $5.5B across 171 financings. @LifeSciVC covers the strength of the biopharma market: https://t.co/h0Uta15w37

Open

Booming VC-Backed Biopharma: Strong Market Despite Pandemic

lifescivc.com

Venture capital is a long investment cycle business, and never before has that been so clear as now in the face of the ongoing COVID pandemic. Even with the unprecedented public equity ...

On Apr 7, 2020

@biospace shared

Biopharma Update on the Novel Coronavirus: April 7 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/O7NJ3IzcqB

Open

Biopharma Update on the Novel Coronavirus: April 7

www.biospace.com

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 7, 2020.

On Apr 9, 2020

@Labiotech_eu shared

Investors must be ready for the #digitization of #biotech. What do you think? 🧐Read the full article by subscribing to Labiotech Insider 30 days for free: 👉🏻 https://t.co/FcJ0AM3Iwx 👈🏻#venturecapital #investment #startup #interview #LBRefresh #membership https://t.co/Uou1rT9Azk

Open

Investors Must Be Ready for the Digitization of Biotech

www.labiotech.eu

For a few decades, the worlds of biotech and digital technology have been on separate paths. Franck Lescure, Partner at the French VC firm Elaia Partners, explains how the two fields are ...

On Apr 7, 2020

@MassBio shared

In this month's #MemberSpotlight, Yohan Tessier of @misprobiotech discusses why next gen #biotechs are seeing the value in controlling their studies in full-service #vivariums & how the company is enabling innovative R&D. Read more: https://t.co/780rTwbaOL https://t.co/fmV8xBV5RU

Open